Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bankruptcy
Pharma
J&J proposes $5.5B deal to resolve 76,000 ovarian cancer claims
J&J has proposed a $5.5B settlement that would resolve roughly 76,000 lawsuits that claim that Johnson’s Baby Powder caused their ovarian cancer.
Kevin Dunleavy
Jul 28, 2026 11:26am
Sackler family, Purdue's $7.4B settlement wins court approval
Nov 18, 2025 3:09pm
Nostrum Labs recalls ulcer drug in wake of shuttering operations
Jul 16, 2025 10:20am
CDMO Resilience to streamline with the closing of 6 facilities
Jun 10, 2025 9:30am
Fierce Biotech
Regeneron’s $256M bid wins 23andMe bankruptcy auction
May 19, 2025 10:37am
Bluebird warns of potential bankruptcy amid buyout delay
May 13, 2025 9:56am
Fierce Biotech
Fierce Biotech
Fierce Biotech
Fierce Biotech
